Depression as a risk factor for poor prognosis among patients with acute coronary syndrome: systematic review and recommendations: a scientific statement from the American Heart Association
- PMID: 24566200
- DOI: 10.1161/CIR.0000000000000019
Depression as a risk factor for poor prognosis among patients with acute coronary syndrome: systematic review and recommendations: a scientific statement from the American Heart Association
Abstract
Background: Although prospective studies, systematic reviews, and meta-analyses have documented an association between depression and increased morbidity and mortality in a variety of cardiac populations, depression has not yet achieved formal recognition as a risk factor for poor prognosis in patients with acute coronary syndrome by the American Heart Association and other health organizations. The purpose of this scientific statement is to review available evidence and recommend whether depression should be elevated to the status of a risk factor for patients with acute coronary syndrome.
Methods and results: Writing group members were approved by the American Heart Association's Scientific Statement and Manuscript Oversight Committees. A systematic literature review on depression and adverse medical outcomes after acute coronary syndrome was conducted that included all-cause mortality, cardiac mortality, and composite outcomes for mortality and nonfatal events. The review assessed the strength, consistency, independence, and generalizability of the published studies. A total of 53 individual studies (32 reported on associations with all-cause mortality, 12 on cardiac mortality, and 22 on composite outcomes) and 4 meta-analyses met inclusion criteria. There was heterogeneity across studies in terms of the demographic composition of study samples, definition and measurement of depression, length of follow-up, and covariates included in the multivariable models. Despite limitations in some individual studies, our review identified generally consistent associations between depression and adverse outcomes.
Conclusions: Despite the heterogeneity of published studies included in this review, the preponderance of evidence supports the recommendation that the American Heart Association should elevate depression to the status of a risk factor for adverse medical outcomes in patients with acute coronary syndrome.
Keywords: AHA Scientific Statements; acute coronary syndrome; coronary heart disease; depression; risk factors.
Comment in
-
Risk factors: Depression recognized as a risk factor in ACS.Nat Rev Cardiol. 2014 Apr;11(4):185. doi: 10.1038/nrcardio.2014.27. Epub 2014 Mar 11. Nat Rev Cardiol. 2014. PMID: 24614114 No abstract available.
Similar articles
-
Depression among patients with acute coronary syndromes.J Cardiovasc Nurs. 2014 Jul;29(4):288-90. doi: 10.1097/JCN.0000000000000164. J Cardiovasc Nurs. 2014. PMID: 24911106 No abstract available.
-
Inclusion of stroke in cardiovascular risk prediction instruments: a statement for healthcare professionals from the American Heart Association/American Stroke Association.Stroke. 2012 Jul;43(7):1998-2027. doi: 10.1161/STR.0b013e31825bcdac. Epub 2012 May 24. Stroke. 2012. PMID: 22627990
-
Scientific Rationale for the Inclusion and Exclusion Criteria for Intravenous Alteplase in Acute Ischemic Stroke: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association.Stroke. 2016 Feb;47(2):581-641. doi: 10.1161/STR.0000000000000086. Epub 2015 Dec 22. Stroke. 2016. PMID: 26696642 Review.
-
Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.Stroke. 2011 Feb;42(2):517-84. doi: 10.1161/STR.0b013e3181fcb238. Epub 2010 Dec 2. Stroke. 2011. PMID: 21127304
-
Duration of Dual Antiplatelet Therapy: A Systematic Review for the 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.Circulation. 2016 Sep 6;134(10):e156-78. doi: 10.1161/CIR.0000000000000405. Epub 2016 Mar 29. Circulation. 2016. PMID: 27026019 Review.
Cited by
-
Secondary Prevention after Myocardial Infarction: What to Do and Where to Do It.Rev Cardiovasc Med. 2022 Jun 8;23(6):210. doi: 10.31083/j.rcm2306210. eCollection 2022 Jun. Rev Cardiovasc Med. 2022. PMID: 39077194 Free PMC article. Review.
-
Traditional and Emerging Sex-Specific Risk Factors for Cardiovascular Disease in Women.Rev Cardiovasc Med. 2022 Aug 16;23(8):288. doi: 10.31083/j.rcm2308288. eCollection 2022 Aug. Rev Cardiovasc Med. 2022. PMID: 39076638 Free PMC article. Review.
-
Depression Following Acute Coronary Syndrome: A Review.Rev Cardiovasc Med. 2023 Sep 5;24(9):247. doi: 10.31083/j.rcm2409247. eCollection 2023 Sep. Rev Cardiovasc Med. 2023. PMID: 39076389 Free PMC article. Review.
-
Integrating depression and acute coronary syndrome care in low resource hospitals in China: the I-CARE randomised clinical trial.Lancet Reg Health West Pac. 2024 Jul 1;48:101126. doi: 10.1016/j.lanwpc.2024.101126. eCollection 2024 Jul. Lancet Reg Health West Pac. 2024. PMID: 39040037 Free PMC article.
-
Depression screening in patients with coronary heart disease : A narrative review of the current evidence.Herz. 2024 Aug;49(4):261-269. doi: 10.1007/s00059-024-05257-y. Epub 2024 Jul 1. Herz. 2024. PMID: 38951196 Review. English.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous